Autoantibodies in type 2 diabetes patients with left ventricular dilatation: biomarkers and/or risk markers?

Cardiology. 2014;129(3):189-90. doi: 10.1159/000366097. Epub 2014 Oct 11.

Author

Martin Landsberger¹

Affiliation

¹ Institute of Pathophysiology, University Medicine Greifswald, Karlsburg, Germany.

PMID: 25323426
DOI: 10.1159/000366097

No abstract available

Publication types

Editorial
Comment

MeSH terms

Autoantibodies / immunology*
Diabetes Mellitus, Type 2 / immunology*
Female
Humans
Hypertension / immunology*
Hypertrophy, Left Ventricular / immunology*
Male
Receptor, Angiotensin, Type 1 / immunology*
Receptors, Adrenergic, beta-1 / immunology*

Substances

Autoantibodies
Receptor, Angiotensin, Type 1
Receptors, Adrenergic, beta-1